Revive Therapeutics is focused on the research, development and commercialization ofnovel therapies and technologies company.
Revive Therapeutics has raised $66K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.
Revive Therapeutics's investors include EMD Financial.
Revive Therapeutics is headquartered in Vaughan, Canada.
Revive Therapeutics is focused on the research, development and commercialization ofnovel therapies and technologies company.
Revive Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Revive Therapeutics — Funding & Investors." VCBacked, July 30, 2025, https://www.vcbacked.co/company/revive-therapeutics. Accessed October 7, 2026.
VCBacked. (2025). Revive Therapeutics — Funding & Investors. Retrieved October 7, 2026, from https://www.vcbacked.co/company/revive-therapeutics
{{cite web |title=Revive Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/revive-therapeutics |website=VCBacked |access-date=October 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated